CA2912274A1 - Method for the diagnosis of niemann-pick disease - Google Patents

Method for the diagnosis of niemann-pick disease

Info

Publication number
CA2912274A1
CA2912274A1 CA2912274A CA2912274A CA2912274A1 CA 2912274 A1 CA2912274 A1 CA 2912274A1 CA 2912274 A CA2912274 A CA 2912274A CA 2912274 A CA2912274 A CA 2912274A CA 2912274 A1 CA2912274 A1 CA 2912274A1
Authority
CA
Canada
Prior art keywords
niemann
biomarker
subject
pick disease
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2912274A
Other languages
English (en)
French (fr)
Inventor
Arndt Rolfs
Hermann Mascher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centogene GmbH
Original Assignee
Pharm Analyt Labor GmbH
Centogene GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharm Analyt Labor GmbH, Centogene GmbH filed Critical Pharm Analyt Labor GmbH
Publication of CA2912274A1 publication Critical patent/CA2912274A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/0027—Methods for using particle spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/08—Sphingolipids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA2912274A 2013-05-14 2014-05-14 Method for the diagnosis of niemann-pick disease Abandoned CA2912274A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13002515.8 2013-05-14
EP13002515 2013-05-14
PCT/EP2014/001306 WO2014183873A1 (en) 2013-05-14 2014-05-14 Method for the diagnosis of niemann-pick disease

Publications (1)

Publication Number Publication Date
CA2912274A1 true CA2912274A1 (en) 2014-11-20

Family

ID=48428310

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2912274A Abandoned CA2912274A1 (en) 2013-05-14 2014-05-14 Method for the diagnosis of niemann-pick disease

Country Status (10)

Country Link
US (1) US10302664B2 (https=)
EP (1) EP2997384B1 (https=)
JP (2) JP6660291B2 (https=)
CA (1) CA2912274A1 (https=)
CY (1) CY1121790T1 (https=)
DK (1) DK2997384T3 (https=)
ES (1) ES2731920T3 (https=)
SA (1) SA515370129B1 (https=)
TR (1) TR201906195T4 (https=)
WO (1) WO2014183873A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2762608T3 (es) * 2013-06-07 2020-05-25 Genzyme Corp Marcador para trastornos de esfingomielinasa ácida y usos del mismo
CA2967504A1 (en) * 2014-11-19 2016-05-26 Centogene Ag Method for the diagnosis of niemann-pick disease using a biomarker
US20210318324A1 (en) 2018-07-05 2021-10-14 The Board Of Regents Of The University Of Oklahoma Gene signatures for cancer characterization and methods of use
HUE071194T2 (hu) * 2019-05-31 2025-08-28 Genzyme Corp Kétdimenziós LC-MS/MS rendszerek

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908190D0 (en) * 1999-04-09 1999-06-02 Pharming Intellectual Pty Bv Diagnosis of lysosomal storage disorders using saposins and other markers
GB0128498D0 (en) * 2001-11-28 2002-01-23 Inst Of Child Health International standards for sphingolipids
CA2524272A1 (en) * 2003-03-31 2004-10-14 Women's And Children's Hospital Multiplex screening for lysosomal storage disorders (lsds)
CN101214249A (zh) * 2003-11-25 2008-07-09 纽约大学西奈山医学院 尼曼-皮克病的基于陪伴分子的治疗
WO2007109881A1 (en) * 2006-03-24 2007-10-04 Phenomenome Discoveries Inc. Biomarkers useful for diagnosing prostate cancer, and methods thereof
US8497122B2 (en) * 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
US8313949B2 (en) * 2009-04-16 2012-11-20 Nextcea Inc. Detecting phospholipidosis and diagnosing lysosomal storage disorders
SI3998078T1 (sl) * 2009-08-28 2026-02-27 Genzyme Corporation Encimsko nadomestno zdravljenje z naraščajočim odmerkom za zdravljenje pomanjkanja kisle sfingomielinaze

Also Published As

Publication number Publication date
JP2020101554A (ja) 2020-07-02
WO2014183873A1 (en) 2014-11-20
CY1121790T1 (el) 2020-07-31
DK2997384T3 (da) 2019-07-22
EP2997384A1 (en) 2016-03-23
SA515370129B1 (ar) 2019-11-18
JP2016522406A (ja) 2016-07-28
US10302664B2 (en) 2019-05-28
JP6989636B2 (ja) 2022-01-05
EP2997384B1 (en) 2019-04-10
ES2731920T3 (es) 2019-11-19
US20160109470A1 (en) 2016-04-21
JP6660291B2 (ja) 2020-03-11
TR201906195T4 (tr) 2019-05-21

Similar Documents

Publication Publication Date Title
AU2021204429B2 (en) Method for the diagnosis of niemann-pick disease
US20180259538A1 (en) Method for the Diagnosis of Gaucher's Disease
US20200284806A1 (en) Method for the Diagnosis of Metachromatic Leukodystrophy
JP6989636B2 (ja) ニーマン・ピック病の診断のための方法
US20180348239A1 (en) Method for the Diagnosis of Niemann-Pick Disease Using a Biomarker
EP2743700A1 (en) Method for the diagnosis of metachromatic leukodystrophy

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190426

FZDE Discontinued

Effective date: 20220527